New syringe design aims to simplify eye injections for common vision disorders

NCT ID NCT07501052

First seen Apr 06, 2026 · Last updated May 08, 2026 · Updated 4 times

Summary

This study tests whether a new prefilled syringe (SCD411) is easy and safe for eye doctors to use when treating wet age-related macular degeneration, retinal vein occlusion, diabetic macular edema, or diabetic retinopathy. About 33 doctors will use the syringe and researchers will track how often they complete tasks correctly and any side effects. The goal is to see if this syringe design works well in real-world use.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for DIABETIC RETINOPATHY are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Locations

  • Center for Retina and Macular Disease

    Winter Haven, Florida, 33880, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • East Florida Eye Institute

    Stuart, Florida, 34994, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Retina Vitreous Surgeons of Central New York, PC

    Liverpool, New York, 13088, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • University Retina & Macula Associates, P.C

    Lemont, Illinois, 60439, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.